Matthew Meyerson

Broad Institute

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index216
i10-index456
Publications1,771
Citations294,273

Grants

36 total · 6 active

NIH #5R35CA197568-12

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$1.0M
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-11

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$992K
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-10

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$1.0M
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

36 total · 6 active

NIH #5R35CA197568-12

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$1.0M
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-11

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$992K
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-10

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$1.0M
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #3R35CA197568-09S1

NKX2-1 Enhancer Amplification and Lineage Addiction in Lung Adenocarcinoma

Active
Amount
$94K
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-09

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$1.0M
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #2R35CA197568-08

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

Active
Amount
$1.1M
Period
2015-08-01 → 2028-07-31
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA154303-10

Project 3: Targeting transcriptional mechanisms of therapeutic resistance in non-small cell lung cancer.

Amount
$348K
Period
2012-05-11 → 2023-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-16

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$261K
Period
2006-03-24 → 2023-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-15

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$108K
Period
2006-03-24 → 2023-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA154303-09

Project 3: Targeting transcriptional mechanisms of therapeutic resistance in non-small cell lung cancer.

Amount
$348K
Period
2012-05-11 → 2022-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA154303-08

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Amount
$1.8M
Period
2012-05-11 → 2022-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #2P01CA154303-06

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Amount
$1.8M
Period
2012-05-11 → 2022-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-05

How do genome alterations cause human lung cancer?

Amount
$997K
Period
2015-08-01 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-04

How do genome alterations cause human lung cancer?

Amount
$1.0M
Period
2015-08-01 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-03

How do genome alterations cause human lung cancer?

Amount
$1.0M
Period
2015-08-01 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-02

How do genome alterations cause human lung cancer?

Amount
$1.0M
Period
2015-08-01 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1R35CA197568-01

How do genome alterations cause human lung cancer?

Amount
$1.0M
Period
2015-08-01 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-14

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$374K
Period
2006-03-24 → 2022-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-13

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$363K
Period
2006-03-24 → 2022-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-12

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$374K
Period
2006-03-24 → 2022-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #2R01CA116020-11

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$374K
Period
2006-03-24 → 2022-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R35CA197568-06

How do genome alterations cause human lung cancer?

Amount
$1.0M
Period
2015-08-01 → 2021-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #4P01CA154303-05

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Amount
$1.7M
Period
2012-05-11 → 2017-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA154303-03

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Amount
$1.7M
Period
2012-05-11 → 2017-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #4R01CA116020-10

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$327K
Period
2006-03-24 → 2017-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-08

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$317K
Period
2006-03-24 → 2017-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-07

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$307K
Period
2006-03-24 → 2017-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #3U24CA143867-05S3

Genome Characterization Center (GCC)

Amount
$188K
Period
2009-09-29 → 2016-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at BROAD INSTITUTE, INC.

NIH #3U24CA143867-05S2

Genome Characterization Center (GCC)

Amount
$365K
Period
2009-09-29 → 2016-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at BROAD INSTITUTE, INC.

NIH #3U24CA143867-05S1

Genome Characterization Center (GCC)

Amount
$948K
Period
2009-09-29 → 2016-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at BROAD INSTITUTE, INC.

NIH #5P01CA154303-04

Administration

Amount
$157K
Period
— → 2016-04-30
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA116020-09

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Amount
$327K
Period
2006-03-24 → 2016-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA109038-09

NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma

Amount
$412K
Period
2005-07-01 → 2015-12-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA109038-08

NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma

Amount
$399K
Period
2005-07-01 → 2014-12-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA154303-07

Core D: Program Administration

Amount
$127K
Period
— → —
PIs
1
Est. capacity / PI
~2 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA154303-02

Administration

Amount
$202K
Period
— → —
PIs
1
Est. capacity / PI
~3 students

Awarded at DANA-FARBER CANCER INST

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 88
Open author page on OpenAlex →